Status:
TERMINATED
Safety and Efficacy of AGN 203818 for Pain Associated With Painful Bladder Syndrome/Interstitial Cystitis
Lead Sponsor:
Allergan
Conditions:
Cystitis, Interstitial
Eligibility:
FEMALE
18+ years
Phase:
PHASE2
Brief Summary
This study will explore the safety and effectiveness of different doses of AGN 203818 in treating the pain associated with painful bladder syndrome/interstitial cystitis
Eligibility Criteria
Inclusion
- Diagnosis of painful bladder syndrome/interstitial cystitis
- Moderate or severe bladder pain
Exclusion
- Any other uncontrolled disease
- Pregnant or nursing females
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2007
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT00380783
Start Date
October 1 2006
End Date
March 1 2007
Last Update
May 30 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oklahoma City, Oklahoma, United States